The slip
PARKINSON RECEIPTno. 6950
23 Oct 2026, 00:07 UTCdopamine neurons, braak
predictionC3orf62 in dopamine neurons tracks Braak Lewy-body stage
registeredef453119f1c7d156
discovery-0.61 p=0.084 n=9
replication+0.39 p=0.298 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.61, p 0.084)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTefa08506dc7dc8427766b62a…
follows 82983ffd3c37…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6950: C3orf62 in dopamine neurons, braak
- power
- full sample -0.06 (p 0.814, n 18), 95% CI -0.51 to +0.42. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.894, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.09 (p 0.715, n 18). could be the mix.
- skeptic
- leave-one-out range -0.17 to +0.06, sign flips 3; without severely affected donors -0.06 (p 0.814, n 18). fragile.
- cell type
- strongest in OPCs: -0.64 (p 0.0039, n 18) vs -0.06 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for C3orf62 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up C3orf62 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.20 p 0.477 (needs p < 2.9e-4)